Bio-IT World - "NIH Awards $45 M for Alzheimer’s Prevention, Novel Drug Targets"

 – September 18, 2013  –– 

The National Institutes of Health distributed $45 million in new funding today to support innovative new studies of Alzheimer's disease. Grants were awarded for clinical trials organized by the Icahn School of Medicine at Mount Sinai along with several other institutions. "With this grant, we can continue to build and refine our predictive model of Alzheimer's disease to yield valuable insights into the complex mechanism of the disease and potential therapies," said Eric Schadt, PhD, Director the Icahn Institute of Multiscale Biology, Chair of Genetics and Genomic Sciences, and Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai, and a principal investigator in the study. Learn more